본문 바로가기

US · 21 CFR

21 CFR Part 211

Current Good Manufacturing Practice for Finished Pharmaceuticals

eCFR, up to date as of 2026-11-12

조항 목차

  1. 211.1Scope.
  2. 211.3Definitions.
  3. 211.22Responsibilities of quality control unit.
  4. 211.25Personnel qualifications.
  5. 211.28Personnel responsibilities.
  6. 211.34Consultants.
  7. 211.42Design and construction features.
  8. 211.44Lighting.
  9. 211.46Ventilation, air filtration, air heating and cooling.
  10. 211.48Plumbing.
  11. 211.50Sewage and refuse.
  12. 211.52Washing and toilet facilities.
  13. 211.56Sanitation.
  14. 211.58Maintenance.
  15. 211.63Equipment design, size, and location.
  16. 211.65Equipment construction.
  17. 211.67Equipment cleaning and maintenance.
  18. 211.68Automatic, mechanical, and electronic equipment.
  19. 211.72Filters.
  20. 211.80General requirements.
  21. 211.82Receipt and storage of untested components, drug product containers, and closures.
  22. 211.84Testing and approval or rejection of components, drug product containers, and closures.
  23. 211.86Use of approved components, drug product containers, and closures.
  24. 211.87Retesting of approved components, drug product containers, and closures.
  25. 211.89Rejected components, drug product containers, and closures.
  26. 211.94Drug product containers and closures.
  27. 211.100Written procedures; deviations.
  28. 211.101Charge-in of components.
  29. 211.103Calculation of yield.
  30. 211.105Equipment identification.
  31. 211.110Sampling and testing of in-process materials and drug products.
  32. 211.111Time limitations on production.
  33. 211.113Control of microbiological contamination.
  34. 211.115Reprocessing.
  35. 211.122Materials examination and usage criteria.
  36. 211.125Labeling issuance.
  37. 211.130Packaging and labeling operations.
  38. 211.132Tamper-evident packaging requirements for over-the-counter (OTC) human drug products.
  39. 211.134Drug product inspection.
  40. 211.137Expiration dating.
  41. 211.142Warehousing procedures.
  42. 211.150Distribution procedures.
  43. 211.160General requirements.
  44. 211.165Testing and release for distribution.
  45. 211.166Stability testing.
  46. 211.167Special testing requirements.
  47. 211.170Reserve samples.
  48. 211.173Laboratory animals.
  49. 211.176Penicillin contamination.
  50. 211.180General requirements.
  51. 211.182Equipment cleaning and use log.
  52. 211.184Component, drug product container, closure, and labeling records.
  53. 211.186Master production and control records.
  54. 211.188Batch production and control records.
  55. 211.192Production record review.
  56. 211.194Laboratory records.
  57. 211.196Distribution records.
  58. 211.198Complaint files.
  59. 211.204Returned drug products.
  60. 211.208Drug product salvaging.
표지·목차 원문

Authority:21 U.S.C. 321, 351, 352, 355, 360b, 360ddd, 360ddd-1, 371, 374; 42 U.S.C. 216, 262, 263a, 264.

Source:43 FR 45077, Sept. 29, 1978, unless otherwise noted.

출처: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · 수집일 2026-11-15

Weekly Newsletter

이런 지적, 매주 월요일 한국어로 받아보세요

FDA·EMA·식약처의 새 지적과 조치를 공식 원문 링크와 함께 보내드립니다. 사이트에 새로운 기능이 생기면 함께 안내드립니다. 구독은 언제든 한 번의 클릭으로 해지할 수 있습니다.

이번 주 소식 먼저 보기

매주 월요일 발송 · 구독 신청 시 확인 메일이 발송됩니다 · 수신거부는 모든 메일 하단에서 가능합니다.